Quarterly report pursuant to Section 13 or 15(d)

Statements of Operations

v3.20.2
Statements of Operations - USD ($)
3 Months Ended 9 Months Ended
Sep. 30, 2020
Sep. 30, 2019
Sep. 30, 2020
Sep. 30, 2019
Statements of Operations        
Revenue, Product and Service [Extensible List] us-gaap:GrantMember us-gaap:GrantMember us-gaap:GrantMember us-gaap:GrantMember
Grant revenue $ 147,787 $ 0 $ 154,302 $ 0
Cost, Product and Service [Extensible List] us-gaap:GrantMember us-gaap:GrantMember us-gaap:GrantMember us-gaap:GrantMember
Cost of grant revenue $ 147,787   $ 154,302  
Gross profit 0 $ 0 0 $ 0
Operating expenses:        
Research and development 494,548 250,773 1,161,537 804,741
General and administrative 677,967 471,272 1,773,615 1,520,325
Total operating expenses 1,172,515 722,045 2,935,152 2,325,066
Loss from continuing operations before interest (1,172,515) (722,045) (2,935,152) (2,325,066)
Other expenses:        
Interest expense, net 1,358 2,763 2,480 3,072
Warrant inducement expense 3,720,866 0 3,720,866 0
Total other expenses 3,722,224 2,763 3,723,346 3,072
Loss from continuing operations (4,894,739) (724,808) (6,658,498) (2,328,138)
Loss from discontinued operations 0 (78,796) 0 (768,047)
Loss on sale of discontinued operations 0 (9,107) 0 (9,107)
Net loss $ (4,894,739) $ (812,711) $ (6,658,498) $ (3,105,292)
Loss from continuing operations per share - basic and fully diluted (in dollars per share) $ (1.28) $ (0.49) $ (2.04) $ (1.60)
Loss from discontinued operations per share - basic and fully diluted (in dollars per share) 0.00 (0.06) 0.00 (0.53)
Net loss per share - basic and fully diluted $ (1.28) $ (0.55) $ (2.04) $ (2.13)
Weighted average number of shares outstanding - basic and fully diluted (in shares) 3,821,717 1,474,001 3,264,860 1,460,507